TAS-117 is a highly potent and selective, oral, allosteric pan-AKT inhibitor [20] with strong anti-proliferative activity against multiple tumor cell lines derived from human cancers, including breast, ovarian, gastric, endometrial, and myeloma (data on file, Taiho Pharmaceutical Co., Ltd.). Here, AKT1 is linked to neoplasm.